Cellectar Biosciences (CLRB) Stock: Gaining On CLR 131 Update
Cellectar Biosciences Inc (NASDAQ: CLRB) is having an incredibly strong start to the trading session this morning, and for good reason. The company provided an update with regard to its lead candidate, CLR 131. Of course, the update excited investors, pushing the stock up. Today, we’ll talk about: The CLR 131 update; what we’re seeing … Read more